drugset / Trial / NCT04905953

Comparison Of Different Doses Of Intrathecal Neostigmine In Prevention Of Post-Dural Puncture Headache

NCT04905953

Phase 2/3 Unknown 274 enrolled Cairo University
RandomizedParallel-groupOpen-labelPrevention

Summary

We hypothesized that; intrathecal administration of neostgmine in spinal anesthesia may have a beneficial role in reduction of the incidence or severity of PDPH.

Timeline

Start
2021-02-01
Primary completion
2022-02-01
Completion
2022-05-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Neostigmine Other / unclassified 10 ug Intrathecal
Subject Neostigmine Other / unclassified 20 ug Intrathecal

Indications